INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
05/03/2026
Voltar para busca
Dado oficial do USPTO
GP PHARM
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
52
Atualização mais recente
06/03/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 5, 42
Data de depósito
24/04/2017
Data de registro
03/04/2018
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
20/11/2024
Última transação
06/03/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
706
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
Barcelona, ES
Examinador
DINALLO, KEVIN M
Localização atual
Historical data usage
Descrição da marca
The brand consists of the terms "GP PHARM" which appear below a design comprising three circles, one above another with a third circle to the left of the other two on an intermediate level.
Titulares e representantes
Titulares
GP Pharm S.A.
Representantes
Elizabeth Lee D'Amore Lucas & Mercanti, LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals used in the cosmetic and pharmaceutical industries for human use
Classe 5
House mark for pharmaceutical preparations other than veterinary preparations; [ Sanitary products for medical purposes, namely, sterilizing preparations and antibacterial preparations; Dietetic substances for medical use, namely, dietetic foods adapted for medical use; Food for babies; Medical plasters, being material for dressings, namely, medical dressings, bandages, gauzes, adhesive bands, tapes; Material for dental fillings and dental impressions; Disinfectants; herbicides; ] pharmaceutical preparations and substances for use in urology, oncology and gynecology
Classe 42
Scientific and technological services, as well as research and design services relating thereto, namely, scientific research for medical purposes in the field of urology, oncology, gynecology, cardiology, neurology, gastroenterology, endocrinology, immunology, rheumatology, ophthalmology, biotechnology, anti-cancer treatments, chemotherapy, hormonal therapies, treatment of pain and inflammation, treatment of muscular disorders, treatment of metabolic disorders and active peptides for medical use; Pharmaceutical research services; Biological research and medical research; Clinical research in the field of urology, oncology, gynecology, cardiology, neurology, gastroenterology, endocrinology, immunology, rheumatology, ophthalmology, biotechnology, chemotherapy, hormonal therapies, analgesia, anti-inflammatory compounds, muscular disorders, metabolic disorders and active peptides for medical use
Publicações
Histórico de despachos e eventos da marca no USPTO.
52 publicações encontradas
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
13/01/2026
XXCR
GENERIC MADRID TRANSACTION CREATED
13/01/2026
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/12/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
09/12/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/12/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/12/2025
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
20/07/2025
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
20/11/2024
71AG
REGISTERED-SEC.71 ACCEPTED
20/11/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
18/11/2024
ES71
TEAS SECTION 71 RECEIVED
27/03/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
03/04/2023
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
06/02/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
18/09/2018
ES7R
TEAS SECTION 7 REQUEST RECEIVED
29/08/2018
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/08/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
14/07/2018
FIMP
FINAL DISPOSITION PROCESSED
14/07/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/07/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
03/04/2018
GPNX
NOTIFICATION PROCESSED BY IB
03/02/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
16/01/2018
PUBO
PUBLISHED FOR OPPOSITION
16/01/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
27/12/2017
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
27/12/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
27/12/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/12/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
09/12/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/12/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
09/12/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/12/2017
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
09/12/2017
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
21/11/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/11/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
08/11/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/11/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
08/11/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/11/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/11/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/11/2017
ALIE
ASSIGNED TO LIE
01/11/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
23/10/2017
RFNT
REFUSAL PROCESSED BY IB
21/10/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
29/09/2017
RFRR
REFUSAL PROCESSED BY MPU
28/09/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
26/09/2017
MAFR
APPLICATION FILING RECEIPT MAILED
26/09/2017
CNRT
NON-FINAL ACTION WRITTEN
25/09/2017
DOCK
ASSIGNED TO EXAMINER
22/09/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
22/09/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
21/09/2017
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace GP PHARM ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.